WHI-P258
CAS No. 21561-09-1
WHI-P258( WHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258 )
Catalog No. M13440 CAS No. 21561-09-1
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 46 | In Stock |
|
10MG | 72 | In Stock |
|
25MG | 140 | In Stock |
|
50MG | 224 | In Stock |
|
100MG | 377 | In Stock |
|
500MG | 861 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWHI-P258
-
NoteResearch use only, not for human use.
-
Brief DescriptionWHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
-
DescriptionWHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK binding negative control in the development of new therapeutics.
-
In Vitro——
-
In Vivo——
-
SynonymsWHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR| JAK3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number21561-09-1
-
Formula Weight281.31
-
Molecular FormulaC16H15N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: <1.2mg/mL
-
SMILESCOC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC
-
Chemical Name6,7-Dimethoxy-N-phenylquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
-
Alflutinib methanesu...
Alflutinib methanesulfonate (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.
-
AZD-3759
A potent, oral active, BBB-penetrating EGFR inhibitor (IC50=7.2 nM, L858R pEGFR).
-
(Rac)-JBJ-04-125-02
JBJ-04-125-02 is effective as a single agent in both in vitro and in vivo models of EGFR-mutant lung cancer.